By Sara Middleton, staff writer
(NaturalHealth365) On February 26, 2021, the pharmaceutical company and COVID vaccine maker Johnson and Johnson (of Janssen Biotech, Inc.) held an advisory committee briefing with their sponsors. In the briefing (page 34), they outlined their plans to test their investigational viral vector vaccine, Ad26.COV2.S, in an upcoming cohort of participants.
But while many in the mainstream media are applauding these “fast-tracked” vaccination trials, many question the safety and necessity of testing a brand-new vaccine in populations as vulnerable as newborn infants.
Johnson & Johnson preparing to trial its genetically engineered, investigational vaccine on adolescents, newborns and pregnant …read more
Source: Natural Health 365
Thanks! Share it with your friends!
Tweet
Share
Pin It
LinkedIn
Google+
Reddit
Tumblr